Improved US performance to pep up Indian pharma Q1 show

[Bilgin]

Improved US performance to pep up Indian pharma Q1 show Analysts at Jefferies India Private Ltd expect strong US but tepid India growth for pharma companies during Q1. In the US, analysts at Jefferies expect sequential improvement for all the major exporters except Cipla.